Mass General Brigham
Based in MA
🤖
AI Overview
With $2.7M in lobbying spend across 31 quarterly filings, Mass General Brigham is a significant lobbying presence.
$2.7M
Total Lobbying Spend
31
Quarterly Filings
1
Lobbying Firms Used
2
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $440K |
| 2019 | $440K |
| 2020 | $440K |
| 2021 | $330K |
| 2022 | $370K |
| 2023 | $275K |
| 2024 | $200K |
| 2025 | $200K |
Lobbying Firms
O'NEILL, ATHY & CASEY, P.C.
What They Lobby For
- H.R. 659, "Standard Merger and Acquisition Reviews Through Equal Rules Act" - provisions related to standardizing FTC and DOJ authority and procedures under the Clayton Act
- H.R. 5003, Restore tax exemption for advanced refunding bonds
- Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Health Care Reform Implementation Medicare Graduate Medical Education Payments H.R. 2267/S. 1301, "Resident Physician Shortage Reduction Act" - provisions related to increasing the number of Medicare-funded residency positions S. 568/H.R.1421, "Improving Access to Medicare Coverage Act" - provisions related to counting outpatient observation services toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare H.R. 1130/S. 397, Fair Medicare Hospital Payments Act of 2017 H.R. 1892, Bipartisan Budget Act of 2018 - provisions related to Medicare hospital payments and policy and funding to address opioid abuse. Monitored discussions related to potential reductions to Medicare payments. H.R. 4392, a bill to prevent cuts to the 340B drug savings program, which would provide relief from deep cuts to payments to hospitals participating in the 340B program Opposed H.R. 4710, a bill to implement reporting requirement for certain 340B participants and to establish a 2-year moratorium on new 340B program participants
- Funding for federally-sponsored medical research Congressional oversight of federally-sponsored research Indirect cost reimbursement for federally-sponsored research
- Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Health Care Reform Implementation Medicare Graduate Medical Education Payments H.R. 1215, "Protecting Access to Care Act" - provisions related to medical liability system reform H.R. 5311/S. 2456, CARA 2.0 - provisions related to federal support and opioid prescribing policy Legislative proposals to combat opioid abuse
- FY 2018 House and Senate Defense Appropriations FY 2018 House and Senate Labor-HHS Appropriations H.R. 1892, Bipartisan Budget Act of 2018 - provisions related to Medicare hospital payments and policy and funding to address opioid abuse. Monitored discussions related to potential reductions to Medicare payments. H.R. 1625, Consolidated Appropriations Act of 2018 - provisions related to health program funding.
- FY 2019 House and Senate Defense Appropriations FY 2019 House and Senate Labor-HHS Appropriations
- Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Health Care Reform Implementation Medicare Graduate Medical Education Payments S. 2597/H.R. 5385, Children's Hospital GME Support Reauthorization Act of 2018 H.R. 959/S. 1109, Title VIII Nursing Workforce Reauthorization Act S. 781/ HR 1876, Good Samaritan Health Professional Act of 2017 - provisions related to limiting the liability of health care professionals who volunteer to provide health care services in response to a disaster H.R. 1215, "Protecting Access to Care Act" - provisions related to medical liability system reform H.R. 5311/S. 2456, CARA 2.0 - provisions related to federal support and opioid prescribing policy S. 2680, Opioid Crisis Response Act H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act - provisions related to IMD exclusion and alignment of 42 CFR Part 2 regulations with HIPPA H.R. 5797, Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act H.R. 6082, Overdose Prevention and Patient Safety Act Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act Legislative proposals to combat opioid abuse
- Legislative proposals affecting Medicare and Medicaid hospital reimbursement policies Health Information Technology Health Care Reform Implementation Medicare Graduate Medical Education Payments H.R. 2267/S. 1301, "Resident Physician Shortage Reduction Act" - provisions related to increasing the number of Medicare-funded residency positions S. 568/H.R.1421, "Improving Access to Medicare Coverage Act" - provisions related to counting outpatient observation services toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare H.R. 1130/S. 397, Fair Medicare Hospital Payments Act of 2017 H.R. 4392, a bill to prevent cuts to the 340B drug savings program, which would provide relief from deep cuts to payments to hospitals participating in the 340B program Opposed H.R. 4710, a bill to implement reporting requirement for certain 340B participants and to establish a 2-year moratorium on new 340B program participants H.R. 6071, Stretching Entity Resources for Vulnerable Communities Act - provisions related to rescinding Medicare reimbursements cuts, codify the definition of patient Additional legislative proposals modifying the 340B program H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act - provisions related to Medicare policy and reimbursement
- H.R. 5645, "Standard Merger and Acquisition Reviews Through Equal Rules Act" - provisions related to standardizing FTC and DOJ authority and procedures under the Clayton Act S. 2847, Standard Merger and Acquisition Reviews Through Equal Rules Act - provisions related to standardizing FTC and DOJ authority and procedures under the Clayton Act
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.